Cassiopea S.p.A.

Hair Loss and Androgenetic Alopecia

Clinical research in androgenetic alopecia focuses on treatment options for male pattern hair loss, with attention to efficacy and safety in adult males.

  • Male pattern hair loss
  • Androgenetic alopecia
  • Topical treatment

The sponsor’s work in this area is centered on dermatology and scalp hair disorders, supporting clinical evaluation of therapies intended for visible hair thinning and loss.

Topical Dermatologic Therapy

Research activity also includes topical dermatologic formulations designed for skin application, with interest in local therapeutic effects and cutaneous tolerability.

  • Clascoterone formulations
  • Skin application
  • Dermatologic treatment

This area reflects a focus on skin-directed therapy within pharmaceutical dermatology, particularly products intended for localized use.

Vasoconstriction and Topical Corticosteroid Potency

Clinical evaluation extends to vasoconstriction testing used in the classification of topical corticosteroid potency, a key domain in dermatologic pharmacology.

  • Vascular narrowing
  • Topical steroid potency
  • Cutaneous pharmacology

These studies are relevant to the assessment of skin vasculature responses and the comparative characterization of anti-inflammatory topical agents.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Effectiveness and Safety of Clascoterone Solution for Treating Male Pattern Hair Loss

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Poland